These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2228518)

  • 21. The synaptic form of acetylcholinesterase binds to cell-surface heparan sulfate proteoglycans.
    Brandan E; Inestrosa NC
    J Neurosci Res; 1986; 15(2):185-96. PubMed ID: 2937928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparan sulfate endoglycosidase and metastatic potential in murine fibrosarcoma and melanoma.
    Ricoveri W; Cappelletti R
    Cancer Res; 1986 Aug; 46(8):3855-61. PubMed ID: 3731061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical characterization of heparan sulfate derived from murine hemopoietic stromal cell lines: a bone marrow-derived cell line S17 and a fetal liver-derived cell line AFT024.
    Arcanjo K; Belo G; Folco C; Werneck CC; Borojevic R; Silva LC
    J Cell Biochem; 2002; 87(2):160-72. PubMed ID: 12244569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlations between heparan sulfate metabolism and hepatoma growth.
    Ishihara M; Conrad HE
    J Cell Physiol; 1989 Mar; 138(3):467-76. PubMed ID: 2522457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan.
    Fedarko NS; Ishihara M; Conrad HE
    J Cell Physiol; 1989 May; 139(2):287-94. PubMed ID: 2715188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of glycosaminoglycans on the growth of cultured tumor cells.
    Nagasawa S
    J Osaka Dent Univ; 1993 Oct; 27(2):121-33. PubMed ID: 8182504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human herpesvirus 8 interaction with target cells involves heparan sulfate.
    Akula SM; Wang FZ; Vieira J; Chandran B
    Virology; 2001 Apr; 282(2):245-55. PubMed ID: 11289807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of experimental lung metastases of Lewis lung carcinoma cells by chemically modified heparin with reduced anticoagulant activity.
    Yoshitomi Y; Nakanishi H; Kusano Y; Munesue S; Oguri K; Tatematsu M; Yamashina I; Okayama M
    Cancer Lett; 2004 Apr; 207(2):165-74. PubMed ID: 15072825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin/heparan sulfate interacting protein expression and functions in human breast cancer cells and normal breast epithelia.
    Jacobs AL; Julian J; Sahin AA; Carson DD
    Cancer Res; 1997 Nov; 57(22):5148-54. PubMed ID: 9371517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of proteoglycan expression on murine tumor cells with different metastatic capacity.
    Timár J; Lapis K
    Anticancer Res; 1990; 10(3):785-7. PubMed ID: 1695080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparan sulfate enhances growth of transformed human cells.
    Matuoka K; Mitsui Y; Murota S
    Cell Struct Funct; 1984 Dec; 9(4):357-67. PubMed ID: 6241504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability.
    Moczar M; Caux F; Bailly M; Berthier O; Doré JF
    Clin Exp Metastasis; 1993 Nov; 11(6):462-71. PubMed ID: 8222394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glycosaminoglycans and extracellular matrix components on metastatic rat rhabdomyosarcoma tumor and myoblast cell proliferation.
    Redini F; Moczar E; Poupon MF
    Clin Exp Metastasis; 1990; 8(5):491-502. PubMed ID: 2390814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study on Lewis lung tumour lines with 'low' and 'high' metastatic capacity. III. Glycosaminoglycan synthesis, transport and degradation in cell lines.
    Pogány G; Moczar E; Jeney A; Timár J; Timár F; Ditrói K; Lapis K
    Clin Exp Metastasis; 1989; 7(6):659-69. PubMed ID: 2776370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between elastin and tumor cell lines with different metastatic potential; in vitro and in vivo studies.
    Timar J; Lapis K; Fulop T; Varga ZS; Tixier JM; Robert L; Hornebeck W
    J Cancer Res Clin Oncol; 1991; 117(3):232-8. PubMed ID: 1851764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells.
    Cheng F; Petersson P; Arroyo-Yanguas Y; Westergren-Thorsson G
    J Cell Biochem; 2001; 83(4):597-606. PubMed ID: 11746503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.
    Nakajima M; Irimura T; Di Ferrante D; Di Ferrante N; Nicolson GL
    Science; 1983 May; 220(4597):611-3. PubMed ID: 6220468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding and internalization of exogenous glycosaminoglycans in weakly and highly metastatic rhabdomyosarcoma cells.
    Redini F; Moczar E; Antoine E; Poupon MF
    Biochim Biophys Acta; 1989 May; 991(2):359-66. PubMed ID: 2785818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth-coupled changes in glucosaminoglycans (heparan sulfate and hyaluronic acid) in normal and transformed human fibroblasts.
    Matuoka K; Mitsui Y; Murota S
    Cell Biol Int Rep; 1985 Jun; 9(6):577-86. PubMed ID: 3161629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions of exogenous heparan sulfate and hyaluronic acid on growth and thymidine incorporation of normal and transformed human fibroblasts. A comparison with the effects of high cell density and low serum concentration and a warning against thymidine incorporation as a measure of DNA synthesis.
    Matuoka K; Mitsui Y; Murota S; Namba M
    Cell Biol Int Rep; 1985 Sep; 9(9):815-24. PubMed ID: 2931185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.